Literature DB >> 6864299

Changes of the blood-brain barrier in experimental metastatic brain tumors.

H Hasegawa, Y Ushio, T Hayakawa, K Yamada, H Mogami.   

Abstract

An experimental model for blood-borne cerebral metastases was developed by introducing Walker 256 carcinoma cells selectively into the intracranial internal carotid artery of rats. This model was used to study the regional capillary permeability of rat brain and metastatic brain tumors of various sizes with the aid of 14C alpha-aminoisobutyric acid (AIB) quantitative autoradiography. The regional capillary permeability varied with the anatomical location and size of the tumor. Intraparenchymal tumors less than 1 mm in diameter showed no increased permeability to AIB. As the tumors enlarged over 1 mm in diameter, the permeability in the intraparenchymal tumors increased proportionally, but remained less than one-third of capillary permeability of subcutaneously transplanted tumors. Capillary permeability in the peripheral invasive part and necrotic center was less than in the viable part of large tumors. Capillary permeability in metastatic tumors of the choroid plexus and meninges was significantly higher than in tumors of the brain parenchyma. The results suggest that the uptake of chemotherapeutic agents that do not cross the blood-brain barrier easily varies with the anatomical location and size of the metastatic tumors.

Entities:  

Mesh:

Year:  1983        PMID: 6864299     DOI: 10.3171/jns.1983.59.2.0304

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  39 in total

1.  [Blood-brain barrier and the penetration of cytostatic drugs].

Authors:  C Unger; H Eibl; H W von Heyden; B Krisch; G A Nagel
Journal:  Klin Wochenschr       Date:  1985-06-18

2.  Lapatinib distribution in HER2 overexpressing experimental brain metastases of breast cancer.

Authors:  Kunal S Taskar; Vinay Rudraraju; Rajendar K Mittapalli; Ramakrishna Samala; Helen R Thorsheim; Julie Lockman; Brunilde Gril; Emily Hua; Diane Palmieri; Joseph W Polli; Stephen Castellino; Stephen D Rubin; Paul R Lockman; Patricia S Steeg; Quentin R Smith
Journal:  Pharm Res       Date:  2011-10-20       Impact factor: 4.200

3.  Chemotherapy administered in conjunction with osmotic blood-brain barrier modification in patients with brain metastases.

Authors:  E A Neuwelt; S A Dahlborg
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

4.  Ultrastructure of capillary walls in human brain tumors.

Authors:  S Shibata
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 5.  Chemotherapy of malignant gliomas.

Authors:  Y Ushio; T Hayakawa; H Hasegawa; K Yamada; N Arita
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

6.  Uptake of drugs and expression of P-glycoprotein in the rat 9L glioma.

Authors:  T Yamashima; T Ohnishi; Y Nakajima; T Terasaki; M Tanaka; J Yamashita; T Sasaki; A Tsuji
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

7.  Capillary permeability in experimental rat glioma and effects of intracarotid CDDP administration on tumor drug delivery.

Authors:  K Ichimura; K Ohno; M Aoyagi; M Tamaki; R Suzuki; K Hirakawa
Journal:  J Neurooncol       Date:  1993-06       Impact factor: 4.130

Review 8.  Novel treatment strategies for brain tumors and metastases.

Authors:  Salma E El-Habashy; Alaa M Nazief; Chris E Adkins; Ming Ming Wen; Amal H El-Kamel; Ahmed M Hamdan; Amira S Hanafy; Tori O Terrell; Afroz S Mohammad; Paul R Lockman; Mohamed Ismail Nounou
Journal:  Pharm Pat Anal       Date:  2014-05

9.  Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors.

Authors:  Hemant Sarin; Ariel S Kanevsky; Haitao Wu; Alioscka A Sousa; Colin M Wilson; Maria A Aronova; Gary L Griffiths; Richard D Leapman; Howard Q Vo
Journal:  J Transl Med       Date:  2009-06-23       Impact factor: 5.531

Review 10.  Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors.

Authors:  Hemant Sarin
Journal:  J Transl Med       Date:  2009-09-01       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.